Across TCGA pan-cancer cohorts, MFAP3 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MFAP3’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where MFAP3 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types MFAP3 is over-expressed in tumor, although a few such as HNSC and LUAD show the opposite, repressed pattern.
HNSC and LUAD are the cancer types where MFAP3 tumor–normal differential expression is most reproducible.